Rep. Will Guzzardi
Filed: 4/16/2018
| |||||||
| |||||||
| |||||||
1 | AMENDMENT TO HOUSE BILL 4900
| ||||||
2 | AMENDMENT NO. ______. Amend House Bill 4900 on page 1, line | ||||||
3 | 5, by replacing "Illinois Generic Drug Pricing Fairness" with | ||||||
4 | "Pharmaceutical and Health Affordability: Restrictions on | ||||||
5 | Manufacturers' Amoral Behavior through Reasonable Oversight"; | ||||||
6 | and
| ||||||
7 | on page 2, line 7, after "Act.", by inserting ""Manufacturer" | ||||||
8 | does not include an entity operating as a wholesale drug | ||||||
9 | distributor as defined in Section 15 of the Wholesale Drug | ||||||
10 | Distribution Licensing Act."; and | ||||||
11 | on page 2, by replacing lines 10 through 14 with the following: | ||||||
12 | "(1) would result in the wholesale acquisition cost of | ||||||
13 | a 30-day supply of the essential off-patent or generic drug | ||||||
14 | exceeding $20 and would result in an increase in the | ||||||
15 | wholesale acquisition cost of the essential off-patent or | ||||||
16 | generic drug of: |
| |||||||
| |||||||
1 | (A) 30% or more within the preceding year; | ||||||
2 | (B) 50% or more within the preceding 3 years; or | ||||||
3 | (C) 75% or more within the preceding 5 years; or"; | ||||||
4 | and | ||||||
5 | on page 3, line 9, after "drug", by inserting "that is | ||||||
6 | ultimately sold in Illinois"; and | ||||||
7 | on page 3, line 13, by replacing "additional costs" with "an | ||||||
8 | increase in the wholesale acquisition cost"; and | ||||||
9 | on page 3, line 15, after "drug", by inserting "or due to | ||||||
10 | market forces in those cases where there are multiple competing | ||||||
11 | generic drug products"; and | ||||||
12 | on page 4, lines 10 and 12, by replacing "price" each time it | ||||||
13 | appears with "wholesale acquisition cost".
|